On 2 March 2022, Zhongshan Chenxinghai Hospital, Hong Kong Integrated Oncology Centre (HKIOC), and DCH Auriga announced the strategic cooperation in support of a National State Council initiative to provide Hong Kong-approved medical treatments to Greater Bay Area (GBA) patients. Under the strategic partnership, DCH Auriga and HKIOC will support Zhongshan Chenxinghai Hospital to offer the newly available…

   

In June 2012, the Auriga Hong Kong team saw an opportunity to help a biotech company offering cancer therapy products meet the needs of their growing business. The company was struggling with a local distributor that could not meet their sales KPIs or the need for one-working day delivery.  Our teams understood the challenges of managing a growing business, offered strong channel relationships…

With key market presence and infrastructure in place, DCH Auriga ensures their partners business needs are served regionally and supports businesses to access the fragmented market using integrated technology platforms and processes, quality access and their comprehensive distribution network. At DCH Auriga we are always looking into better warehousing storage and efficiency solutions that provides…

Hong Kong. DCH Auriga announced today that it has successfully implemented the latest version of JDA Warehouse Management System (WMS) and has fully integrated it into its ERP system. The Asian-based integrated market management leader who specialises in healthcare has now successfully gone live with JDA WMS in two of its distribution centres located in Singapore and in Hong Kong. As part of its continued…

DCH Auriga, one of the largest healthcare distributors in Hong Kong with decades of experience managing sophisticated pharmaceutical supply chains, is pleased to announce it has been selected to manage the storage and delivery of the Fosun Pharma-BioNTech BNT162b2 vaccine in Hong Kong as the exclusive logistics partner of Shanghai Fosun Pharmaceutical (Group) Co., Limited (Stock Code: 600196.SH, 02196.HK)…

Auriga Hong Kong supports Baxter with home delivery for chronic care Sometimes, opportunity knocks on the door. In 2015, Baxter appointed Auriga as their sole distributor of renal dialysis solution in Hong Kong - a complex home delivery healthcare product which appeared to be a fairly new market for Auriga to explore. Baxter's operations included receiving, picking and delivering prescription…